![](https://assets.isu.pub/document-structure/240524015959-bfea2d88d1bc981e02e07a19a659b546/v1/8d47b9203abcb3e75eefe2f0723875f6.jpeg)
![](https://assets.isu.pub/document-structure/240524015959-bfea2d88d1bc981e02e07a19a659b546/v1/2b2ab103a78d8db8e9a80ff3eac48947.jpeg)
Intravenous Cannula Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Intravenous Cannula market is projected to reach a value of $3.5 billion by 2025, with a CAGR of 5.8% from 2020 to 2025. This growth is driven by increasing prevalence of chronic diseases, advancements in healthcare infrastructure, and rising demand for minimally invasive procedures. Market conditions are highly competitive, with key players focusing on product innovation and strategic collaborations to maintain their market position. Request Sample Report
◍ iLife
◍ Disposafe
◍ Lars Medicare Pvt
◍ Vogt Medical
◍ NEOTEC
◍ Delta Med
◍ BD
◍ BS Medical
◍ Armstrong Medical
◍ JIMIT MEDICO SURGICALS
◍ Omex Medical
The competitive landscape of the Intravenous Cannula Market includes companies such as iLife, Disposafe, Lars Medicare Pvt, Vogt Medical, NEOTEC, Delta Med, BD, BS Medical, Armstrong Medical, JIMIT MEDICO SURGICALS, and Omex Medical. These companies offer a wide range of intravenous cannulas to healthcare providers, contributing to the market's growth.
- BD: $17.1 billion
- Armstrong Medical: $104 million
- Omex Medical: $12 million
Request Sample Report
Hospital
Clinic
Others
Request Sample Report
Intravenous Cannula for People
Intravenous Cannula for Animals
Request Sample Report
$ X Billion USD